Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Tracon Pharmaceuticals, Inc. | tcon-ex321_6.htm |
| EX-31.1 - EX-31.1 - Tracon Pharmaceuticals, Inc. | tcon-ex311_7.htm |
| EX-10.18 - EX-10.18 - Tracon Pharmaceuticals, Inc. | tcon-ex1018_453.htm |
| EX-10.11 - EX-10.11 - Tracon Pharmaceuticals, Inc. | tcon-ex1011_389.htm |
| EX-10.10 - EX-10.10 - Tracon Pharmaceuticals, Inc. | tcon-ex1010_390.htm |
| EX-10.6 - EX-10.6 - Tracon Pharmaceuticals, Inc. | tcon-ex106_388.htm |
| EX-10.4 - EX-10.4 - Tracon Pharmaceuticals, Inc. | tcon-ex104_387.htm |
| EX-4.9 - EX-4.9 - Tracon Pharmaceuticals, Inc. | tcon-ex49_1187.htm |
| 10-K - 10-K - Tracon Pharmaceuticals, Inc. | tcon-10k_20191231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
|
|
|
(1)Registration Statement (Form S-8 No. 333-201808) pertaining to the 2011 Equity Incentive Plan, 2015 Equity Incentive Plan, and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (2)Registration Statement (Form S-8 No. 333-209592) pertaining to the 2015 Equity Incentive Plan, and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (3)Registration Statement (Form S-8 No. 333-216347) pertaining to the 2015 Equity Incentive Plan, and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (4)Registration Statement (Form S-8 No. 333-223333) pertaining to the 2015 Equity Incentive Plan, and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (5)Registration Statement (Form S-8 No. 333- 229988) pertaining to the 2015 Equity Incentive Plan, and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., (6)Registration Statement (Form S-1 No. 333-216962) of TRACON Pharmaceuticals, Inc., (7)Registration Statement (Form S-1 No. 333- 234651) of TRACON Pharmaceuticals, Inc., (8)Registration Statement (Form S-3 No. 333-224809) of TRACON Pharmaceuticals, Inc.; and (9)Registration Statement (Form S-3 No. 333- 229990) of TRACON Pharmaceuticals, Inc. |
of our report dated February 27, 2020, with respect to the consolidated financial statements of TRACON Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2019.
|
|
/s/ Ernst & Young LLP |
San Diego, California
February 27, 2020